Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Gastaldi

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
BMJ Neurology Open|November 29, 2023
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in <i>GBA</i>-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolFabiana Colucci, Micol Avenali, Rosita De Micco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2026
Validation of the MOG-AR Score: A Retrospective Multicenter StudySara Carta, Riccardo Tiberi, Nicola De Rossi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 19, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and DiscrepanciesSara Carta, Elia Sechi, Alessandro Dinoto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 29, 2022
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGADMargherita Nosadini, Michael Eyre, Thea Giacomini, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2019
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotypeAndrea Cortese, Raffaella Lombardi, Chiara Briani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2025
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor EncephalitisChiara Milano, Ezgi Saylam, Claudia Papi, et al.
Journal of Applied Biomaterials & Functional Materials|July 13, 2018
Binders alternative to Portland cement and waste management for sustainable construction-part 1Luigi Coppola, Tiziano Bellezze, Alberto Belli, et al.
Journal of Applied Biomaterials & Functional Materials|July 12, 2018
Binders alternative to Portland cement and waste management for sustainable construction - Part 2Luigi Coppola, Tiziano Bellezze, Alberto Belli, et al.
Frontiers in Neurology|January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic MyelopathyJohn V Pluvinage, David Acero-Garces, Giacomo Greco, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
BMJ Neurology Open|November 29, 2023
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in <i>GBA</i>-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolFabiana Colucci, Micol Avenali, Rosita De Micco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2026
Validation of the MOG-AR Score: A Retrospective Multicenter StudySara Carta, Riccardo Tiberi, Nicola De Rossi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 19, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and DiscrepanciesSara Carta, Elia Sechi, Alessandro Dinoto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 29, 2022
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGADMargherita Nosadini, Michael Eyre, Thea Giacomini, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2019
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotypeAndrea Cortese, Raffaella Lombardi, Chiara Briani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2025
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor EncephalitisChiara Milano, Ezgi Saylam, Claudia Papi, et al.
Journal of Applied Biomaterials & Functional Materials|July 13, 2018
Binders alternative to Portland cement and waste management for sustainable construction-part 1Luigi Coppola, Tiziano Bellezze, Alberto Belli, et al.
Journal of Applied Biomaterials & Functional Materials|July 12, 2018
Binders alternative to Portland cement and waste management for sustainable construction - Part 2Luigi Coppola, Tiziano Bellezze, Alberto Belli, et al.
Frontiers in Neurology|January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic MyelopathyJohn V Pluvinage, David Acero-Garces, Giacomo Greco, et al.
Pageof 12